234 related articles for article (PubMed ID: 18851793)
21. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
22. Endometriosis-associated ovarian cancer: a clinicopathologic review.
Steed H; Chapman W; Laframboise S
J Obstet Gynaecol Can; 2004 Aug; 26(8):709-15. PubMed ID: 15307975
[TBL] [Abstract][Full Text] [Related]
23. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study.
Mhawech P; Kinkel K; Vlastos G; Pelte MF
Int J Gynecol Pathol; 2002 Oct; 21(4):401-6. PubMed ID: 12352189
[TBL] [Abstract][Full Text] [Related]
24. Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer.
Moro F; Magoga G; Pasciuto T; Mascilini F; Moruzzi MC; Fischerova D; Savelli L; Giunchi S; Mancari R; Franchi D; Czekierdowski A; Froyman W; Verri D; Epstein E; Chiappa V; Guerriero S; Zannoni GF; Timmerman D; Scambia G; Valentin L; Testa AC
Ultrasound Obstet Gynecol; 2018 Oct; 52(4):535-543. PubMed ID: 29418038
[TBL] [Abstract][Full Text] [Related]
25. Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis.
Khan KN; Masuzaki H; Fujishita A; Kitajima M; Sekine I; Matsuyama T; Ishimaru T
Hum Reprod; 2005 Jul; 20(7):2004-13. PubMed ID: 15831511
[TBL] [Abstract][Full Text] [Related]
26. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features.
Brown DL; Doubilet PM; Miller FH; Frates MC; Laing FC; DiSalvo DN; Benson CB; Lerner MH
Radiology; 1998 Jul; 208(1):103-10. PubMed ID: 9646799
[TBL] [Abstract][Full Text] [Related]
27. [Morphology and histogenesis of ovarian endometriosis as potential precancerous condition].
Kolosov AE
Vopr Onkol; 1977; 23(3):23-31. PubMed ID: 898792
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic features of ovarian cancer in patients with ovarian endometrioma.
Kawaguchi R; Tsuji Y; Haruta S; Kanayama S; Sakata M; Yamada Y; Fujita H; Saito H; Tsuneto K; Kobayashi H
J Obstet Gynaecol Res; 2008 Oct; 34(5):872-7. PubMed ID: 18834345
[TBL] [Abstract][Full Text] [Related]
29. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical localisation of aromatase and its correlation with progesterone receptors in ovarian epithelial tumours.
Kitawaki J; Noguchi T; Yamamoto T; Yokota K; Maeda K; Urabe M; Honjo H
Anticancer Res; 1996; 16(1):91-7. PubMed ID: 8615676
[TBL] [Abstract][Full Text] [Related]
31. Predictive factors for the presence of malignant transformation of pelvic endometriosis.
Kadan Y; Fiascone S; McCourt C; Raker C; Granai CO; Steinhoff M; Moore RG
Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():23-7. PubMed ID: 25522113
[TBL] [Abstract][Full Text] [Related]
32. Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.
Del Carmen MG; Smith Sehdev AE; Fader AN; Zahurak ML; Richardson M; Fruehauf JP; Montz FJ; Bristow RE
Cancer; 2003 Oct; 98(8):1658-63. PubMed ID: 14534882
[TBL] [Abstract][Full Text] [Related]
33. Increased steroid receptor RNA activator protein (SRAP) accompanied by decreased estrogen receptor-beta (ER-β) levels during the malignant transformation of endometriosis associated ovarian clear cell carcinoma.
Lin K; Zhan H; Ma J; Xu K; Wu R; Zhou C; Lin J
Acta Histochem; 2014 Jun; 116(5):878-82. PubMed ID: 24704270
[TBL] [Abstract][Full Text] [Related]
34. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
Munksgaard PS; Blaakaer J
Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
[TBL] [Abstract][Full Text] [Related]
35. [Ovarian clear cell carcinoma derived from endometriotic cyst: a clinicopathological analysis of 54 cases].
Zhu Q; Lu Y; Rao Y; Ning Y; Qu Y; Wang L; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):838-42. PubMed ID: 26887772
[TBL] [Abstract][Full Text] [Related]
36. [Ovarian cancer and endometriosis].
Spaczyński M; Kedzia W
Ginekol Pol; 2001 May; 72(5):268-72. PubMed ID: 11526755
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of patients in Japan with ovarian cancer presumably arising from ovarian endometrioma.
Taniguchi F; Harada T; Kobayashi H; Hayashi K; Momoeda M; Terakawa N
Gynecol Obstet Invest; 2014; 77(2):104-10. PubMed ID: 24503885
[TBL] [Abstract][Full Text] [Related]
38. Disappearance of steroid hormone dependency during malignant transformation of ovarian clear cell cancer.
Akahane T; Sekizawa A; Okuda T; Kushima M; Saito H; Okai T
Int J Gynecol Pathol; 2005 Oct; 24(4):369-76. PubMed ID: 16175084
[TBL] [Abstract][Full Text] [Related]
39. Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts.
Yoshimoto C; Iwabuchi T; Shigetomi H; Kobayashi H
Cancer Biomark; 2015; 15(4):493-9. PubMed ID: 25835178
[TBL] [Abstract][Full Text] [Related]
40. Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system.
Engemise SL; Willets JM; Taylor AH; Emembolu JO; Konje JC
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):101-6. PubMed ID: 21470761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
